Adverse drug reactions triggered by the common HLA-B*57:01 variant: a molecular docking study.
about
Combinatorial In Silico Strategy towards Identifying Potential Hotspots during Inhibition of Structurally Identical HDAC1 and HDAC2 Enzymes for Effective Chemotherapy against Neurological Disorders.Prediction on the risk population of idiosyncratic adverse reactions based on molecular docking with mutant proteins.Adverse drug reactions triggered by the common HLA-B*57:01 variant: virtual screening of DrugBank using 3D molecular docking.Critical assessment of approaches for molecular docking to elucidate associations of HLA alleles with adverse drug reactions
P2860
Adverse drug reactions triggered by the common HLA-B*57:01 variant: a molecular docking study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Adverse drug reactions trigger ...... nt: a molecular docking study.
@en
Adverse drug reactions trigger ...... nt: a molecular docking study.
@nl
type
label
Adverse drug reactions trigger ...... nt: a molecular docking study.
@en
Adverse drug reactions trigger ...... nt: a molecular docking study.
@nl
prefLabel
Adverse drug reactions trigger ...... nt: a molecular docking study.
@en
Adverse drug reactions trigger ...... nt: a molecular docking study.
@nl
P2860
P1476
Adverse drug reactions trigger ...... nt: a molecular docking study.
@en
P2860
P2888
P356
10.1186/S13321-017-0202-6
P577
2017-03-04T00:00:00Z
P6179
1084252450